Pharmaceutical

AmyriAD leaves no leaf unturned with upcoming Phase III...

The company aims to drive a small molecule resurgence with its lead Alzheimer’s ...

Signal: UK online pharmacies selling prescription drugs...

A BBC team was able to buy over 1600 prescription pills by supplying fake data, ...

Intellia propels into 2024 with CRISPR pipeline updates

Intellia Therapeutics announced its clinical goals for the next few years, pushi...

Insilico teams up with Menarini for breast cancer KAT6 ...

Menarini subsidiary Stemline will receive upfront and milestone payments, potent...

MOMA Therapeutics and Roche sign cancer drug discovery ...

MOMA Therapeutics and Roche have signed a strategic partnership and licensing ag...

AbbVie and Umoja to develop new CAR-T therapies for cancer

AbbVie and Umoja Biopharma partnered for the development of in-situ CAR-T cell t...

STAT+: Illumina chief commercial officer leaves to lead...

Tousi’s selection is part of a bid by Delfi to expand its commercial efforts and...

At JPM, how much health policy talk should we expect?

How much health policy talk should we expect at #JPM2024?

STAT+: Allogene to pursue new strategy for development ...

“The CAR-T space has become very crowded,” said David Chang, in announcing a str...

Baby monitor videos yield evidence for long-suspected l...

“It was the videos alone that implicated seizures. Otherwise, we would have not ...

STAT+: Feng Zhang’s year-old CRISPR delivery startup Ae...

Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang, has laid...

STAT+: Another major pharma company departs BIO

UCB left the biotech industry group BIO at the end of 2023, the second major mem...

STAT+: FDA is blasted by advocates for pursuing a deal ...

Advocacy groups are blasting the FDA's plan to work with a Denver Health surveil...

Why CG Oncology will be the first test of 2024’s IPO wa...

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: We’re reading about CVS dropping H...

CVS Health will no longer offer AbbVie's Humira to patients in its commercial pr...

STAT+: An injectable gel enters the male birth control ...

An injectable, reversible hydrogel made by Contraline could fill the male birth ...